UK: First Instance Declares German CureVac Patent On MRNA Vaccine Against Covid-19 Invalid - Maucher Jenkins

On 19 December 2023, the Federal Patent Court declared the German part of the European patent EP 1 857 122 B1 of CureVac of Tübingen invalid following an action for revocation brought by BioNTech from Mainz.